Hepatology
News
Direct-acting antiviral therapy boosts survival for infected HCC patients
Adults with a history of hepatocellular carcinoma had a significantly reduced risk of death after treatment of HCV infections with DAAs.
News
Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality
In sharp contrast with the viral hepatitis findings, mortality rates among patients with ALD and NAFLD have increased.
News
Some HCV medications associated with serious liver injury
In many cases, the medications should never have been prescribed, according to the FDA.
News
USPSTF issues draft recommendation statement for HCV screening in adults
The proposal represents an update and expansion of USPSTF’s current recommendation.
Conference Coverage
NAFLD unchecked is a ‘harbinger of deadly dysmetabolism’
SAN DIEGO –
Literature Review
Treatment for hepatitis C reduces risk of Parkinson’s disease
Data support the hypothesis that hepatitis C virus infection is a risk factor for incident Parkinson’s disease.
News
Survey: Palliative care blocked by many barriers in end-stage liver disease
Formal palliative care training was lacking among the physicians surveyed.
Conference Coverage
Ribavirin boosts HCV genotype 3 eradication in compensated cirrhotic patients
VIENNA – Data from more than 14,000 English patients showed incremental benefit from ribavirin when treating hepatitis C genotype 3 virus.
News
Tailoring the Mediterranean diet for NAFLD
Keys to success included providing recipes and meal planners, education on how lifestyle and diet contribute to NAFLD, and offering care in person...
Conference Coverage
Tenofovir disoproxil treated HBV with fewer future HCCs
VIENNA - Chronic hepatitis B virus-infected patients treated with tenofovir disoproxil fumarate developed significantly fewer hepatocellular...